Wellgistics Health (WGRX) has expanded its agreement with Tollo Health to offer the first GLP-1 companion muscle loss medical food to its 6,500+ independent pharmacy network and physicians. The product is a branded version of a proprietary formulation that has been widely studied in metabolic dysfunction, with patients presenting diabetes type 2, heart failure, and COPD. Wellgistics will be selling the medical food as an adjunct to GLP-1 therapies to help mitigate muscle loss during weight loss while on therapy and to mitigate weight after discontinuation.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGRX:
- Wellgistics Health launches EinsteinRx prescription management solution
- Wellgistics Health Inc. Converts Debt to Equity
- Wellgistics Health Partners with DataVault AI for Blockchain Platform
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- Why Is Wellgistics Health Stock (WGRX) Up 135% Today?